Why the study?
Does pronethalol treat exercise-induced paroxysmal ventricular tachycardia in a patient?
Does pronethalol treat exercise-induced paroxysmal ventricular tachycardia in a patient?
Pronethalol, a β-adrenergic blocking drug, demonstrated effectiveness in treating exercise-induced paroxysmal ventricular tachycardia in a single patient.
May support pronethalol in exercise-induced paroxysmal VT; leaves open confirmation in controlled trials.
The β-adrenergic blocking drug pronethalol was effective in the treatment of a patient with exercise-induced paroxysmal ventricular tachycardia. Adrenergic stimuli are considered important in initiating this arrhythmia. The mode of action of pronethalol is briefly discussed in relation to other antiarrhythmic agents.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (1965) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: